Alexandra Gaspar is a dedicated researcher focused on the design and synthesis of biologically active small molecules aimed at enhancing human health and well-being. She holds a pre-Bologna degree in Pharmaceutical Sciences from the University of Porto and a Master's degree from the University of Lisbon, where she graduated with distinction (18 out of 20). Alexandra completed her PhD at the University of Porto in 2013, earning the prestigious Paul Ehrlich MedChem Euro-PhD prize for her dissertation in 2014. As an Assistant Researcher at the Faculty of Science, University of Porto, Alexandra has been actively engaged in innovative drug discovery. Her expertise includes the design, synthesis, and structural elucidation of bioactive small molecules to address critical health challenges, such as neurodegenerative diseases and antimicrobial resistance (AMR). Her scientific contributions include 55 peer-reviewed publications, three national patents, and recognition in prominent scientific rankings, including the "World's Top 2% Scientists" list. As the Principal Investigator of the project "A Trojan Horse Strategy to Discover and Develop New Antibacterials for Superbugs," Alexandra has led groundbreaking research into new therapeutic pathways in antibiotic development. In addition to her research, she is committed to academic teaching and lecturing undergraduate and master's students at the University of Porto. She promotes critical thinking and empowers the next generation of scientists. Throughout her career, Alexandra has supervised over 20 students and fostered collaborative research initiatives within the scientific community, positively impacting the academic and professional development of young researchers. Furthermore, Alexandra is passionate about translating scientific discoveries into practical applications, which is evident from her active participation in spin-off initiatives and her commitment to technology transfer. Through ongoing participation in collaborative projects and international conferences, she continuously advances public health goals and strives to deliver innovative solutions to some of the most pressing global health issues of our time.